secwatch.observer — SEC 8-K summary
======================================

Issuer:     AETHLON MEDICAL INC (AEMD)
CIK:        0000882291
Form:       8-K
Filed at:   2026-07-31T12:00:57+00:00
Accession:  0001683168-26-005850
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aethlon Medical announces 1-for-5 reverse stock split effective July 31, 2026
-----------------------------------------------------------------------------

- Reverse stock split approved by board; no stockholder vote required under Nevada law.
- Effective 10:00 a.m. ET on July 31, 2026; split-adjusted trading begins August 4, 2026 under symbol AEMD.
- Pre-split shares: 3,249,569; post-split approx 649,914; authorized shares reduced from 100M to 20M.
- No fractional shares issued; rounding up to whole share; CUSIP changes to 00808Y703.
- Purpose: dilution management and continued compliance with Nasdaq minimum bid price rule.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882291/000168316826005850/0001683168-26-005850-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882291/000168316826005850/aethlon_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-005850

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer